Additionally, in our work, patients were stratified according to their p53 status, into wild-type p53 or mutated p53, which is not usually performed despite it being mutated in around 43% of cases, which may affect multiple pathways involved in tumour development [24]. The gene discussed is TP53; the disease is neoplasm.